Waters Corporation reported a 4% increase in sales, reaching $741 million in Q2 2023. GAAP EPS was $2.55, while non-GAAP EPS reached $2.80. The company experienced double-digit growth in the Industrial and Academic & Government markets, offset by pharmaceutical market weakness in China.
Sales increased by 4% as reported, reaching $741 million.
Organic constant currency sales grew by 3%.
GAAP EPS was $2.55, and non-GAAP EPS was $2.80.
Double-digit growth was seen in the Industrial and Academic & Government markets.
Waters Corporation provided financial guidance for the third quarter and full year 2023. They anticipate Q3 organic constant currency sales to decline between -4% and -2%, with reported sales growth expected in the range of 1% to 3%. Full-year organic constant currency sales growth is projected to be between 0.5% and 1.5%, with reported sales growth expected in the range of 3% to 4%.
Visualization of income flow from segment revenue to net income